Panaku00e8s Partners backs ambitious early-stage startups and SMEs developing innovative medical devices, diagnostics, biotechnology, and healthcare IT solutions. The firm leverages a deep network of clinicians and industrial partners to help portfolio companies accelerate clinical development and scale globally.
About Panakes Partners
Panakes Partners is an Italy-based, healthcare-specialist venture firm focused on medical devices, diagnostics and biotechnology across Europe. The firm is one of a small group of dedicated European medtech investors, with deep technical diligence capability and strong relationships across European clinical, regulatory and corporate stakeholders. Investments typically span seed through Series B in companies with strong scientific or engineering IP and a credible path to CE Mark, FDA clearance and meaningful clinical adoption. Check sizes are typically in the EUR 1M to EUR 8M range across initial and follow-on positions, with the ability to lead European rounds and strong capacity to syndicate with international medtech specialists for later financings. For healthcare founders, Panakes is highly relevant if you are building a European-anchored medical device, diagnostic or healthcare technology company with strong scientific or engineering foundations and a clear regulatory plan. The firm is a poor fit for digital-only health, services businesses, US-only consumer health and most pure-software plays without a regulated device or diagnostic component. Founders should expect rigorous technical and clinical diligence, hands-on board engagement, and strong opinions on regulatory and reimbursement strategy. Entry is best via warm introductions from European medtech advisors, clinical KOLs in the firm’s network, or co-investing VCs on prior deals. The Italian and broader European healthcare ecosystem operates on relationships, so a thoughtful warm introduction will dramatically outperform cold outbound. Confirm fund stage, geographic mandate and current deployment pace early in conversations.
Founder reviews
Other portfolio companies
Companies in Panakes Partners's portfolio not currently in our directory.
- NanoPhoria Bioscience · 2025
- Lymphatica Medtech · 2024
- deepull · 2025
- Complement Therapeutics · 2023
- Allotex · 2023
- Diadem · 2018
- Neuromod Devices · 2023
- CorFlow Therapeutics · 2024
- Medical Microinstruments (MMI) · 2022
- Endostart · 2018
- InnovHeart · 2022
- DISCO Pharmaceuticals · 2024
Team
Pitch / review this investor
Have you raised from Panakes Partners? Founders only — share your honest experience (anonymous OK, moderated before publishing).